FIELD: medicine.
SUBSTANCE: invention refers to medical products, particularly to ytterbium porphyrin complexes (YPC) which can be used in experimental oncology, namely in examination of tissue malignisation in experimental animals. As fluorescent tags to diagnose malignant growths, Yb-complexes of substituted 5,10,15,20-tetrapyrazolyl porphyrines are used. 
.
EFFECT: there are offered ytterbium tetrapyrazolyl porphyrine complexes as fluorescent tags to diagnose malignant growths.
2 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING BORATED PORPHYRINS | 2013 |
|
RU2551539C2 |
| YTTERBIUM COMPLEX OF 2,4-DIMETHOXYHEMATOPORPHYRIN IX DIPOTASSIUM SALT AS FLUORESCENT TAG FOR EARLY CANCER DIAGNOSIS | 2009 |
|
RU2411243C1 |
| NANOCOMPOSITION FOR FLUORESCENT DIAGNOSIS OF MALIGNANT TUMOURS | 2014 |
|
RU2578976C2 |
| DEVICE FOR LUMINISCENT DIAGNOSTICS OF NEOPLASMS | 2012 |
|
RU2483678C1 |
| NANOCOMPOSITES FOR MAGNETOLUMINESCENT THERANOSTICS OF NEOPLASMS | 2021 |
|
RU2766513C1 |
| COMPOSITE NANOPARTICLES FOR PHOTODYNAMIC DIAGNOSIS | 2011 |
|
RU2463074C1 |
| YTTERBIUM COMPLEXES OF PORPHYRINES AS LUMINESCENT AGENTS FOR DIAGNOSTICS OF MALIGNANT TUMORS | 1985 |
|
SU1340087A1 |
| METHOD OF PRODUCING A DIPOTASSIUM SALT OF THE 2,4-DI(α-METHOXYETHYL)DEUTEROPORPHYRIN IX ACETYLACETONATE YTTERBIUM COMPLEX | 2019 |
|
RU2697418C1 |
| PHARMACEUTICAL COMPOSITION FOR FLUORESCENT DIAGNOSTICS OF PATHOLOGICAL CHANGES IN SKIN AND MUCOUS MEMBRANES | 2016 |
|
RU2617045C1 |
| FLUORINATED PORPHYRIN DERIVATIVES EXHIBITING ANTI-TUMOR ACTIVITY | 2019 |
|
RU2707754C1 |
